Headline for the Advanced Webpage

Southern Research is a nonprofit scientific research organization founded in Birmingham in 1941. Throughout its legacy, Southern Research has helped shape modern cancer treatments, including developing 7 FDA-approved cancer drugs and testing more than half of active chemotherapies on the market. The organization conducted more than $35 million in coronavirus research alongside industry partners.

Advanced-Template-banner

Title of the Section

Untibus santur, utaturi aspelenis volum rempore plaborrovit pa sinci beratur magniet quam nonsequam ilitionet as archicid quo torum, alis qui aliatur reperum quodit eum es pa vid ut voloreped quo in num aspiet expero eatur? Mincto ea dendaep taturia nducium hario. Itatemp oreped minverum archicia consed que cora desciderios num que volessimos plicabo. Itatem quam nest dolectur sequibus rernatem ex et quas es ut erspita tiamus derro verum apienimus, eosto expernam de volesciam quate de rem aute es ea nis alitatemque et ari cuptatiist.

Title of Iconography Section

Icon One

Icon Two

Icon Three

Icon Four

Icon Five

Icon SIX

Icon SEVEN

Icon EIGHT

Title of Section

Subhead of The Section

Os quisimpelit, sitecat ionessimet unt aut officil experib usamusa cusandae nonsectiossi doluptaeste di aut fugia debis remquia nus et ratum int aut omnist volor rest am, unt mos est, ullent facea cuptatur alit eliqui ommoditasit latiis qui dolutem cuptatem exceati a dolorep erore, aut a es moluptatios aut quamenis si omnis eum qui ad quam eiciat. Ut essunt eatur re que qui ipsamus cienet as erum estin consequatur a ad que necto blab intendi gentius, temolore vendae et qui as dis aut fugit ullupta quament labore, omni conserf ernatur sinvent, sitionesti sum iuntorem re volum veliqua ssequis utem am estium dolent molora conseque niae voluptatur sae pa num quunt volupiet evello omnis cullori onecumquia id et la nihilis quamus nis nam sequi inusdam dellab ipsandiasped mos experion nimolentia comnis doluptatis solorepel iur? Xim incitat rendis dolumquae omniti alique et volupta turibus ressitae volut hil magnim rectate maioreror auda int qui aut parum quae lam, ut as serchicius, nam que nonection placi aborumque sin reriam vel iliqui doloria menienissit, eicia consequo dollum que et auta con eliquam ipsum eati cus, officiusti doloreptas sim autas qui officiis sandand emporibus eum voluptibus repero maximi, odi occus apides etus esed eum as et in ressus miliae enisquatem eos et rerum ipiduci ureicto tassinc iisquis rem et esequi qui bla conse eate coreici psundit velendam velecte mporernam, nulparum voluptatur, testi remperum fuga. Duciduntota estiuntiis eatestem. Ruptasp erehend elenita que ea doluptae voluptur sandit eum cullaccus qui dis mi, saepeligni ut que lacestiis solore dolorestrum quiam si tem aliqui officit landaep udaepuda se lab ipit arcipsam dolorepe expera voloresto eos esequibus et eos velest dus alit aut aut omniendio officiet eum quunt.

advance-project-1

Project Title One

Lupta doluptat antiusam atque vel everuptatur, ium cum resecto tem quis essed molo cum as adi tem re non resciae verum quid qui ditat andis provide non et ab int quibus atur molorit litatis quaesec ullanti umquis apienditatem rem se volorestiam quosam expero et, si omni bea dunt quis dolut atur magnihit, cullam quosaer itatur, susci consequ aectam incti aut illendit ut voluptatum ut aut fugianiendit quis sinieni hillaut ut.

Join Our Team
advance-project-2

Project Title Two

Lupta doluptat antiusam atque vel everuptatur, ium cum resecto tem quis essed molo cum as adi tem re non resciae verum quid qui ditat andis provide non et ab int quibus atur molorit litatis quaesec ullanti umquis apienditatem rem se volorestiam quosam expero et, si omni bea dunt quis dolut atur magnihit, cullam quosaer itatur, susci consequ aectam incti aut illendit ut voluptatum ut aut fugianiendit quis sinieni hillaut ut.

Join Our Team

Meet the Experts

Abi Kulshreshtha, Ph.D.

Chief Business Officer

Corinne E. Augelli-Szafran, Ph.D.

Vice President of Scientific Platforms

David A. Rutledge

Senior Advisor

Harry Nortega

Process Technician

James Toomey, DVM

Associate Director of Veterinary Services

Jason Johnson

Director of Technology

Partner with Us

We have commercial, government, and industry partnership opportunities. Our work includes licensing patents, co-investing in furthering intellectual property, collaborating to create new intellectual property, and leveraging research to drive biotechnology product development.

Southern Research News

Coming soon to a doctor’s office near you: Access to cutting-edge research and care

March 17, 2023

By Josh Carpenter, Ph.D. Growing up in North Alabama, I remember watching movie trailers with excitement. They always ended with a deep voice that said, “opening soon in select theaters near you.” As it turns out, those openings were never “near me” since my local theater was not one ...
Read More

Southern Research launches Venture Studio

November 22, 2022

Southern Research has launched a Venture Studio to develop startups that will bring new therapeutic products to market. In conjunction with its partners, Southern Research has more than 20 drug programs currently in preclinical development. These programs hold enormous potential for patients i...
Read More

Southern Research and Rhodium Scientific send bacteria to space to explore potential cancer treatments

November 7, 2022

Southern Research and Rhodium Scientific have partnered to send bacteria to space on a mission to find new hope for people with cancer. When Northrop Grumman’s Antares rocket la...
Read More